Federal Court Rejects Injunction Over Authorized Generic of Depression Drug

A federal court in New Jersey Oct. 20 rejected Mylan Inc.'s bid for a preliminary injunction barring GlaxoSmithKline and Apotex Inc. from selling an authorized generic version of GSK’s extended-release antidepressant Paxil CR (paroxetine hydrochloride extended-release tablets) (Mylan Inc. v. SmithKlineBeecham Corp.).

Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey issued a not-for-publication opinion in the case Oct. 20, after denying Mylan’s motion for preliminary injunction Oct. 18 (8 PLIR 1340, 10/22/10). Pisano found that he could not justify granting the “drastic remedy of a preliminary injunction” because Mylan ...